Compare BIO & PSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | PSO |
|---|---|---|
| Founded | 1952 | 1844 |
| Country | United States | United Kingdom |
| Employees | 7450 | 17116 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Books |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 8.2B |
| IPO Year | N/A | N/A |
| Metric | BIO | PSO |
|---|---|---|
| Price | $269.20 | $13.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $358.50 | N/A |
| AVG Volume (30 Days) | 248.0K | ★ 950.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.46% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.51 | $5.90 |
| Revenue Next Year | $3.17 | $4.88 |
| P/E Ratio | ★ $9.72 | $14.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $211.43 | $12.02 |
| 52 Week High | $343.12 | $16.62 |
| Indicator | BIO | PSO |
|---|---|---|
| Relative Strength Index (RSI) | 43.59 | 61.43 |
| Support Level | $266.71 | $12.92 |
| Resistance Level | $289.61 | $13.34 |
| Average True Range (ATR) | 7.77 | 0.23 |
| MACD | 0.46 | 0.05 |
| Stochastic Oscillator | 34.76 | 81.55 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
UK-listed Pearson is a testing and educational provider. Pearson's primary operations are in assessment and qualification testing and higher education, but they also provide English education and testing, virtual learning, prehiring testing and screening, and upskilling/reskilling. The company divested noncore businesses, including the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider.